Article

Precision aberrometer provides high accuracy, range, and resolution

WaveFront Sciences presents the COAS-HD Model 2800 high-definitionprecision aberrometer. The Model 2800 (2800 is the number ofsamples in a 9.5-mm pupil) extends the capability ofwavefront-based ophthalmic metrology and provides the physicianwith an ultra-detailed map of the eye.

WaveFront Sciences presents the COAS-HD Model 2800 high-definition precision aberrometer. The Model 2800 (2800 is the number of samples in a 9.5-mm pupil) extends the capability of wavefront-based ophthalmic metrology and provides the physician with an ultra-detailed map of the eye.

The newest member of the Complete Ophthalmic Analysis System (COAS) family of precision aberrometers is based on Shack-Hartmann wavefront-sensing technology to provide unparalleled accuracy, range, and resolution for ophthalmic research, according to the company.

The aberrometer's wavefront maps are reconstructed directly from the sensor array without mathematical interpolations or smoothing. In addition, the device provides 25th-order Zernike reconstructions and has sufficient resolution to provide on-screen displays of striae, corneal scarring, flap folds, cataracts, incipient keratoconus, and advanced keratoconus.

The device characterizes up to 10 D of astigmatism throughout the spherical range of 7 to -15 D. Pupil diameters as large as 9.5 mm are measurable. The combination of large pupil diameter and cylinder range means all patients can be measured with the device.

For more information, visit WaveFront Sciences at Booths 801 and 803.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
© 2025 MJH Life Sciences

All rights reserved.